300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Oil and Gas
Film
Retail
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Recruiting
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Vickers Venture Partners, VC Fund

Vickers Venture Partners

VC Fund

Singapore, Singapore

Vickers Venture Partners is a global venture capital firm focused on deep tech investments worldwide. The partners’ track records include hits such as Baidu.com, Inc, Focus Media Holding Ltd, Kongzhong Corp, Cambridge Real Estate Investment Trust, Sunfun Info Co., Asian Food Channel, UUCUN, TWG Tea, RTG Asia, JJE, Hillstone, M-Daq and Mainspring.The total market value of the companies that the partners have helped grow exceeds US$70 billion today. Vickers Venture Partners was founded by Dr Finian Tan together with his co-founders Dr Khalil Binebine, Dr Jeffrey Chi, Dr Damian Tan, Linda Li and Raymond Kong in 2005. It is headquartered in Singapore with offices in Shanghai, Hong Kong, New York, Miami, Silicon Valley and London.

Total investments:
63
Last investment:
Lead investor:
54%
Fund size:
$256M
Last fund:

Last updated:

Industries Vickers Venture Partners invests in

Health CareBiotechnologyMobileAppsInternet

Stages Vickers Venture Partners invests in

Series ASeries BSeedSeries CSeries D

Countries Vickers Venture Partners invests in

United StatesChinaSingaporeUnited KingdomCanada

Round sizes

Seed $1M–$4MSeries A $3M–$38MSeries B $6.5M–$133M

Contacts

NameEmailPhoneSocials
See all 9 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$1M–$4M
Series A
$3M–$38M
Series B
$6.5M–$133M

Investment Focus

Industry

  • Health Care 7 (11%)
  • Biotechnology 7 (11%)
  • Mobile 6 (10%)
  • Apps 3 (5%)
  • Internet 3 (5%)
See all 77 industries →

Stage

  • Series A 22 (35%)
  • Series B 12 (19%)
  • Seed 5 (8%)
  • Series C 4 (6%)
  • Series D 2 (3%)
See all 8 stages →

Country

  • United States 8 (13%)
  • China 5 (8%)
  • Singapore 5 (8%)
  • United Kingdom 4 (6%)
  • Canada 2 (3%)
See all 10 countries →

Team

NameTitleInvestmentsLinksEmail
Chris Ho
Chris Ho Associate Director
Associate Director Total investments: 0
Find email
Damian Tan
Damian Tan Co-Founding Partner, Managing Director & Member of the Investment Committee
Co-Founding Partner, Managing Director & Member of the Investment Committee Total investments: 0
Find email
Eikhalil Binebine
Eikhalil Binebine Senior Consultant
Senior Consultant Total investments: 0 Find email
Finian Tan
Finian Tan Founder
Founder Total investments: 11
Find email
Jeffrey Chi Vice Chairman - Asia
Vice Chairman - Asia Total investments: 0 Find email
See all 9 team members →

Investments

CompanyDescriptionRoundLinks
HyperAccel provides hardware solutions for developing AI applications. $37.8M / Series A / Dec 18, 2024
Mithradote Bio is a biotechnology company developing a novel medication to help prevent drug-facilitated sexual assault. $1M / Seed / Oct 02, 2024
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017. $85M / Series C / May 09, 2024
Eavor is a technology based energy company that provides a clean, carbon-neutral, scalable, baseload power solution. The company's solution represents a truly scalable form of clean baseload power. They achieve this by mitigating or eliminating many of the issues that have hindered traditional geothermal solutions. The system is made withexisting commercial componentry configured in a completely novel way. They use the most recent advances in drilling techniques and merge them with the latest heat to power generation technology to create a scalable, steady, and reliable source of green power. $131.9M / Series B / Oct 25, 2023
AWAK Technologies develop wearable dialysis machines, 1kg and battery-operated, for continuous dialysis. The company was certified by SGS for ISO 13485 Quality Management System in September 2008 with the scope of designing, manufacturing and distributing medical devices.The Automated Wearable Artificial Kidney (AWAK) is based on tidalperitoneal dialysis. The technology is based on research by Profs David Lee & Martin Roberts of UCLA and VA Systems.The engineering and development of AWAK is done in Singapore with the collaboration of Temasek Polytechnic.The company has completed the R&D and is now in the clinical trial stage, targeting both FDA and CE certifications. The AWAK Regular Cartridge, is currently in pilot production stage and expected to enter clinical trial by the end of 2012. This wearable artificial kidney operates continuouslyand functions like a normal kidney. Being small , light (less than 1 kg) and battery-operated, the patients will be able to go about having daily routines, with no restriction to lifestyles such as work, travel and leisure. $20M / Series B / Sep 13, 2023
Eavor is a technology based energy company that provides a clean, carbon-neutral, scalable, baseload power solution. The company's solution represents a truly scalable form of clean baseload power. They achieve this by mitigating or eliminating many of the issues that have hindered traditional geothermal solutions. The system is made withexisting commercial componentry configured in a completely novel way. They use the most recent advances in drilling techniques and merge them with the latest heat to power generation technology to create a scalable, steady, and reliable source of green power. $60M / Series B / Jun 14, 2023
Qianyuhui Environmental Protection is a provider of comprehensive solutions for carbon emissions. Seed / Nov 24, 2022
RWDC develops biodegradable bioplastic that can be used to make cutlery, drinking straws and cup lids, foodand beverage packaging, as well as diapers, among other things. It produces medium-chain-length polyhydroxyalkanoate(mcl-PHA), which are naturally produced by bacterial fermentation of plant-based oils or sugar. RWDC’s PHA is certified to befully biodegradable in soil, water and marine conditions. $95M / Series B / Nov 22, 2021
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017. $29M / Series B / Aug 05, 2021
Eavor is a technology based energy company that provides a clean, carbon-neutral, scalable, baseload power solution. The company's solution represents a truly scalable form of clean baseload power. They achieve this by mitigating or eliminating many of the issues that have hindered traditional geothermal solutions. The system is made withexisting commercial componentry configured in a completely novel way. They use the most recent advances in drilling techniques and merge them with the latest heat to power generation technology to create a scalable, steady, and reliable source of green power. $39.9M / Venture - Series Unknown / Feb 16, 2021
See all 63 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Oil and Gas
Film
Retail
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Recruiting
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Vickers Venture Partners invest in?

Vickers Venture Partners invests primarily in Health Care, Biotechnology and Mobile startups, most often at Series A and Series B stage. Most of the 63 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Vickers Venture Partners's check size?

Vickers Venture Partners typically joins rounds of $1M–$4M at Seed, $3M–$38M at Series A and $6.5M–$133M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Vickers Venture Partners participates in.

How do I contact Vickers Venture Partners?

Public channels for Vickers Venture Partners include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Vickers Venture Partners?

The team at Vickers Venture Partners includes Chris Ho (Associate Director), Damian Tan (Co-Founding Partner, Managing Director & Member of the Investment Committee) and Eikhalil Binebine (Senior Consultant), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Vickers Venture Partners Vickers Venture Partners Find emails